Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07419425 · ClinicalTrials.gov registry record · Phase 4
My Path to Quit Tobacco
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,550
- Enrollment target
NCT07419425: Recruiting Phase 4 study, sponsored by University of Wisconsin, Madison.
NCT07419425 is a Phase 4 study that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 1,550 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (199% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07419425, a Phase 4 study, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,550 participants
- Enrollment target
Study Summary
The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.
Primary Outcome
The primary outcome for this study will be biochemically confirmed (anabasine less than 2 ng/ml) 7-day point-prevalence smoking abstinence at 26- weeks post-TQD
Interventions
- DRUG Nicotine patch
- OTHER Quitline Counseling Phone Calls
- OTHER Counseling Sessions
- OTHER Pathways to Freedom
- OTHER Monetary Incentive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,550 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-01 |
| Phase | Phase 4 |
What NCT07419425 shows while recruiting
NCT07419425 is an interventional study that assigns participants to a tested intervention. Its 1,550 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (199% higher).
The record links to 0 conditions, and to 5 interventions - of which Nicotine patch is the first listed.
NCT07419425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07419425 about?
NCT07419425 is a clinical study titled "My Path to Quit Tobacco". The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at prom...
What is the current status of trial NCT07419425?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,550 participants. The study started on 2026-07. Estimated completion is 2030-01.
What interventions are being tested in trial NCT07419425?
The interventions under investigation include: Nicotine patch (DRUG), Quitline Counseling Phone Calls (OTHER), Counseling Sessions (OTHER), Pathways to Freedom (OTHER), Monetary Incentive (OTHER).
Who is sponsoring clinical trial NCT07419425?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07419425's enrollment target sits among peer trials
1,550 50th of 2000 higher than 1,951 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia